Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19316| Title: | Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Angiogenesis Inhibitors/administration & dosage/adverse effects/*therapeutic use,Chemotherapy, Adjuvant,Combined Modality Therapy,Constipation/chemically induced,Disease Progression,Female,Fibroblast Growth Factor 2/blood,Follow-Up Studies,Glioblastoma/drug therapy/radiotherapy,Glioma/*drug therapy/radiotherapy,Humans,Hypnotics and Sedatives/adverse effects,Male,Middle Aged,Neoplasm Recurrence, Local/*drug therapy,Peripheral Nervous System Diseases/chemically induced,Remission Induction,Supratentorial Neoplasms/*drug therapy/radiotherapy,Survival Rate,Thalidomide/administration & dosage/adverse effects/*therapeutic use,Tumor Markers, Biological/blood |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19316 |
| ISSN: | 0732-183X |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/10673511 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
